C1 Esterase Inhibitor Deficiency


Article Author:
Matthew Kerrigan


Article Editor:
Pratiksha Naik


Editors In Chief:
Timothy Craig
Yoon Kim
Robert Hostoffer


Managing Editors:
Carrie Smith
Abdul Waheed
Frank Smeeks
Kristina Soman-Faulkner
Scott Dulebohn
Sobhan Daneshfar
William Gossman
Pritesh Sheth
John Shell
Matthew Varacallo
Ahmad Malik
Mark Pellegrini
James Hughes
Beata Beatty
Richard Ciresi
Hajira Basit
Phillip Hynes


Updated:
2/5/2019 10:28:38 PM

Introduction

Hereditary angioedema, otherwise known as C1 esterase deficiency, is defined by recurrent episodes of angioedema without urticaria or pruritus. These skin conditions typically involve the legs, hands, face, upper respiratory tract, as well as the gastrointestinal tract. This disorder can lead to airway edema and potentially asphyxiation due to laryngeal swelling. Associated symptoms typically include abdominal pain and vomiting secondary to gastrointestinal involvement.[1]

Etiology

Hereditary angioedema results from excessive production of bradykinin. Bradykinin is a vasodilator which causes the larynx to become engorged and swollen, threatening the airway. Due to this pathway, the swelling is not amenable to antihistamines as it is not a histamine-mediated process. While there are other forms of hereditary angioedema, deficiency or dysfunction in C1 inhibitor is the most common form. C1 inhibitor is an acute phase reactant and a serine protease inhibitor (serpin). Serpins inhibit the steps in the lectin complement pathway as well as kinin producing pathways. While C1 inhibitor has many functions, its function in the kinin pathway which leads to angioedema.[2]

While it is uncertain what causes the initial molecular events leading to this angioedema, it is believed activated factor XII of the coagulation cascade and kallikrein catalyze the cleavage of kininogen which produces bradykinin. C1 inhibitor usually limits this bradykinin production by inhibiting kallikrein and factor XIIa. Bradykinin is a potent vasodilator due to multifactorial downstream effects on smooth muscle in blood vessels. This activity, in turn, leads to edema of surrounding tissues and most importantly, the airway. In individuals with a deficiency of C1 inhibitor, this process proceeds unchecked and leads to gross vasodilation and angioedema.[1]

Epidemiology

Hereditary angioedema has an incidence of approximately 1 in 50000 individuals. While there are nearly 300 pathogenic variants, most are inherited in an autosomal dominant fashion with approximately 25% of cases arising from de novo mutations. This condition leads to about 15000 to 30000 emergency department visits per year.[1]

Pathophysiology

The most clinically significant sequelae of C1 inhibitor deficiency is the potential for laryngeal edema and subsequent asphyxiation due to angioedema from unchecked bradykinin effects. The pathophysiology of C1 esterase inhibitor deficiency largely stems around the increased bradykinin production. Increased levels of bradykinin then lead to smooth muscle relaxation in the walls of blood vessels which causes edema. If severe enough, the airway can be compromised and effectively swollen closed, preventing air movement into and out of the lungs.[3]

History and Physical

When suspecting C1 esterase deficiency, key historical findings such as a family history for the disease or upper airway swelling may be noted. Additionally, a history of unexplained recurrent episodes of self-limited colicky abdominal pain may be present. A history of angioedema without urticaria, pruritus, ACE inhibitor, NSAID, or allergic exposure is highly suggestive as well. Common sites that are affected include the hands and feet as well.[1]

Evaluation

When suspecting C1 esterase inhibitor deficiency, it is generally may present with airway compromise from laryngeal edema or a more benign presentation of unexplained hands and feet swelling. First, care should be taken to ensure the airway is secured; this can be via traditional airway methods but will be made difficult due to airway swelling. Further evaluation should take place by a trial basis of classic allergic airway swelling management (epinephrine, steroids, antihistamines). In the case of C1 inhibitor deficiency, these methods will not work. At this point, a presumptive diagnosis can be made, but for definitive diagnosis, clinicians can obtain C4 levels. In the case of C1 inhibitor deficiency, C4 levels will be low. Further testing can include C1NH protein levels and function studies for definitive diagnosis.[4]

Treatment / Management

Management of C1 esterase inhibitor deficiency is mostly in response to airway compromise. If only mild symptoms present and patient has a known diagnosis, it is reasonable to manage conservatively with observation. If more severe symptoms and impending airway compromise are present, a definitive airway is necessary. Presumptive treatment with epinephrine, steroids, and antihistamines is recommended of the undifferentiated patient with airway compromise secondary to laryngeal edema. However, in the setting of C1 esterase inhibitor deficiency, this is ineffective but should be attempted as allergic airway compromise is more common, and these methods have a high reward with relatively little downside.[5]

Specific therapy for C1 esterase inhibitor deficiency with laryngeal edema involves replacing the deficient enzyme. The easiest way is to give human plasma which contains C1 esterase inhibitor. An initial dose of human plasma is 2 units. C1INH concentrate derived from human plasma may be a therapeutic option. The initial dose is 1500 units.[6]

More specific, less widely used medications include Icatibant and ecallantide. Icatibant is a synthetic bradykinin B2-receptor antagonist while ecallantide is a recombinant plasma kallikrein inhibitor.[5][6]

Differential Diagnosis

Differential diagnosis in the setting of airway edema includes:

  • Anaphylaxis/allergic
  • ACE inhibitor-induced edema
  • Idiopathic
  • Autoimmune disorders
  • Superior vena cava syndrome
  • Thyroid disorders
  • Cheilitis granulomatosa
  • Trichinosis 

The possible differentials can broaden when symptoms relate solely to extremity swelling: 

  • Lymphedema
  • Deep vein thrombosis
  • Cellulitis

Prognosis

Depending on the response to therapy, the patient should return to normal health. Occasionally patients are very resistant to therapy and will require intubation. After the acute event and extubation, the patient should have a full recovery. The chance of recurrence, however, is always present.[7]

Complications

The most severe complication is airway compromise requiring intubation or surgical airway; standard airway procedures and protocols should manage this situation.[6]

Consultations

If attempts at airway are unsuccessful, a surgical airway may be necessary. Consultation with the anesthesia team may be of some benefit if there is the possibility a difficult airway.

Deterrence and Patient Education

  • Avoid physical and psychological stressors
  • Medications to avoid include: estrogen, tamoxifen, and ACE inhibitors
  • Patients who are to undergo oral surgery should receive prophylaxis which includes attenuated androgens, regular C1INH infusions, and tranexamic acid infusion

Enhancing Healthcare Team Outcomes

When caring for a patient with hereditary angioedema, the ABC's of resuscitation should be first and foremost. Assigning team roles and frequently assessing the patient for airway compromise is paramount. Having the appropriate tools for intubation such as visual laryngoscopes and back up airway devices are part of the key to success. Patients with even concern for airway compromise should be monitored closely in the intensive care setting.[6]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE courses, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

C1 Esterase Inhibitor Deficiency - Questions

Take a quiz of the questions on this article.

Take Quiz
C1 esterase inhibitor deficiency disease shows what type of genetic inheritance pattern?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A young female has stress-induced edema of the tongue, lips and occasionally the larynx. She also has episodic abdominal pain. Select the protein that has decreased functionality or low levels.



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

C1 Esterase Inhibitor Deficiency - References

References

Fragnan NTML,Tolentino ALN,Borba GB,Oliveira AC,Simões JA,Palma SMU,Constantino-Silva RN,Grumach AS, Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases). Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2018 Nov 14     [PubMed]
Bindke G,Schorling K,Wieczorek D,Kapp A,Wedi B, [Gender aspects in angioedema]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2019 Feb     [PubMed]
Ivanov I,Matafonov A,Sun MF,Mohammed BM,Cheng Q,Dickeson SK,Kundu S,Verhamme IM,Gruber A,McCrae K,Gailani D, A mechanism for hereditary angioedema with normal C1-inhibitor: an inhibitory regulatory role for the factor XII heavy chain. Blood. 2018 Dec 27     [PubMed]
Mehmood A,Abdullah HMA,Inayat F,Ullah W, Wolf in the sheep's clothing: intestinal angioedema mimicking infectious colitis. BMJ case reports. 2018 Dec 13     [PubMed]
Banerji A,Riedl MA,Bernstein JA,Cicardi M,Longhurst HJ,Zuraw BL,Busse PJ,Anderson J,Magerl M,Martinez-Saguer I,Davis-Lorton M,Zanichelli A,Li HH,Craig T,Jacobs J,Johnston DT,Shapiro R,Yang WH,Lumry WR,Manning ME,Schwartz LB,Shennak M,Soteres D,Zaragoza-Urdaz RH,Gierer S,Smith AM,Tachdjian R,Wedner HJ,Hebert J,Rehman SM,Staubach P,Schranz J,Baptista J,Nothaft W,Maurer M, Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. JAMA. 2018 Nov 27     [PubMed]
Barmettler S,Li Y,Banerji A, New and evolving therapies for hereditary angioedema. Allergy and asthma proceedings. 2019 Jan 1     [PubMed]
    [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Allergy and Immunology. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Allergy and Immunology, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Allergy and Immunology, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Allergy and Immunology. When it is time for the Allergy and Immunology board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Allergy and Immunology.